Achieve Life Sciences (ACHV) Deferred Taxes (2015 - 2017)
Achieve Life Sciences (ACHV) recorded quarterly Deferred Taxes of -$2.9 million in Q3 2017, down 2260.48% on a QoQ basis from -$124000.0 in Q1 2017, and down 2036.5% year-over-year from $151149.3 in Q3 2016.
Achieve Life Sciences (ACHV) Deferred Taxes (2015 - 2017) Analysis & Trends
Achieve Life Sciences has disclosed Deferred Taxes across 3 years of filings, most recently posting -$2.9 million for Q3 2017.
- Quarterly Deferred Taxes fell 2036.5% year-over-year to -$2.9 million in Q3 2017, while the trailing twelve-month figure through Dec 2017 was -$3.2 million (down 530.56% YoY) and the FY2017 annual result came in at -$3.1 million, down 505.36% from the prior year.
- Deferred Taxes slipped to -$2.9 million in Q3 2017, from -$124000.0 in the prior quarter.
- Over five years, Deferred Taxes peaked at -$118000.0 in Q1 2016 and troughed at -$2.9 million in Q3 2017.
- A 3-year average of -$566000.0 and a median of -$127000.0 in 2016 frame the typical range for Deferred Taxes.
- Annual changes were most pronounced in 2016 — Deferred Taxes jumped 68.8% — and 2017, when it sank 2036.5%.
- Tracing ACHV's Deferred Taxes over 3 years: stood at -$407000.0 in 2015, then soared by 68.8% to -$127000.0 in 2016, then sank by 2204.72% to -$2.9 million in 2017.
- Business Quant data shows ACHV's Deferred Taxes at -$2.9 million in Q3 2017, -$124000.0 in Q1 2017, and -$127000.0 in Q4 2016.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Deferred Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | - |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | -859,000.00 |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | -65.30 Mn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | - |
| 10 | Achieve Life Sciences | 93.71 Mn | 63.22 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2017 | -2.93 Mn |
| Mar 31, 2017 | -124,000.00 |
| Dec 31, 2016 | -127,000.00 |
| Sep 30, 2016 | -137,000.00 |
| Jun 30, 2016 | -122,000.00 |
| Mar 31, 2016 | -118,000.00 |
| Dec 31, 2015 | -407,000.00 |